XH02

· Peking Union Medical College Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XH02, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism [EARLY_Phase 1]